Scientific article
Review
English

Prevention of hypocalcemia and hypoparathyroidism after total thyroidectomy. Recommendations of the Francophone Association of Endocrine Surgery (AFCE) with the French Society of Endocrinology (SFE) and the French Society of Nuclear Medicine (SFMN)

Published inJournal of visceral surgery, vol. 160, no. 3S, p. S95-S109
Publication date2023-05-19
First online date2023-05-19
Abstract

Postoperative hypoparathyroidism, resulting from removal and/or devascularization of one or more parathyroid glands, is a feared complication of total thyroidectomy. Two forms, which are distinguished by their frequency, their time to onset and their duration as well as by their presentation, must be individualized: early postoperative hypocalcemia, often secondary to early hypoparathyroidism is a frequent and often transient situation occurring within the first days after surgery; permanent hypoparathyroidism, which is rarer, manifests when parathyroid function remains impaired for more than six months after surgery. Because of their severity, these conditions must be known and ideally prevented during total thyroidectomy. The objective of this article is to provide surgeons with practical recommendations for the prevention, diagnosis, and treatment of hypoparathyroidism after total thyroidectomy. These recommendations, which are the fruit of a medico-surgical consensus, were developed by the Francophone Association of Endocrine Surgery (AFCE), the French Society of Endocrinology (SFE) and the French Society of Nuclear Medicine and Molecular Imaging. (SFMN). The content, grade and level of evidence for each recommendation was decided after consultation within a panel of experts, based on an analysis of recent literature.

Keywords
  • Hypocalcemia
  • Hypoparathyroidism
  • Thyroidectomy
Citation (ISO format)
FREY, Samuel et al. Prevention of hypocalcemia and hypoparathyroidism after total thyroidectomy. Recommendations of the Francophone Association of Endocrine Surgery (AFCE) with the French Society of Endocrinology (SFE) and the French Society of Nuclear Medicine (SFMN). In: Journal of visceral surgery, 2023, vol. 160, n° 3S, p. S95–S109. doi: 10.1016/j.jviscsurg.2023.05.004
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN1878-7886
26views
0downloads

Technical informations

Creation07/06/2023 11:41:36
First validation25/03/2024 10:13:45
Update time25/03/2024 10:13:45
Status update25/03/2024 10:13:45
Last indexation01/11/2024 08:59:21
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack